Company Overview of Burrill Life Sciences Capital Fund III, L.P.
Burrill Life Sciences Capital Fund III, L.P. specializes in seed, early stage, late stage, and mezzanine investments. It prefers to invest in biotechnology, life sciences, pharmaceuticals, diagnostics, devices, human healthcare, wellness and nutraceuticals, agbio, and industrial biotechnology sectors. The fund invests globally. It invests between $1 million and $20 million on an average in its portfolio companies.
One Embarcadero Center
San Francisco, CA 94111
Founded in 2005
Key Executives for Burrill Life Sciences Capital Fund III, L.P.
Similar Private Companies By Industry
|440 Financial Group of Worcester Inc||United States|
|Crews & Associates, Inc.||United States|
|Belstone Capital LLC||United States|
|Kicking the Can, L.L.C.||United States|
|1 Road Partners LLC||United States|
Recent Private Companies Transactions
December 19, 2013
|Neos Therapeutics Inc.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Mclean, VA | Freddie MacPosted: Apr 10
- Miami, FL | PwCPosted: Jun 28
- Washington D.c., DC | Fannie MaePosted: Nov 15
- New York, NY | Union BankPosted: Feb 19
Sponsored Financial Commentaries
To contact Burrill Life Sciences Capital Fund III, L.P., please visit venture.burrillandco.com/funds-23-Burrill_Life_Sciences_Capital_Fund_III_LP__Active.html. Company data is provided by Capital IQ. Please use this form to report any data issues.